MedTrace Logo

Comprehensive Genomic Analysis in Tissue and Blood Samples From Young Patients With Lung Cancer

NCT02273336 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2021-11-18

No results posted yet for this study

Summary

This research trial studies genomic analysis in tissue and blood samples from young patients with lung cancer. Identifying specific gene mutations (changes in deoxyribonucleic acid \[DNA\]) may help doctors tailor treatment to target the specific mutations and help plan effective treatment.

Conditions

Interventions

OTHER

cytology specimen collection procedure

Undergo tissue and blood sample collection

OTHER

laboratory biomarker analysis

Correlative studies

Sponsors & Collaborators

  • Foundation Medicine

    collaborator INDUSTRY

  • Addario Lung Cancer Medical Institute

    collaborator OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Southern California

    lead OTHER

Principal Investigators

  • Barbara Gitlitz, MD · University of Southern California

Eligibility

Max Age
39 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-22
Primary Completion
2020-08-08
Completion
2020-09-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02273336 on ClinicalTrials.gov